NCT06232785View on ClinicalTrials.gov

Gynecologic Endoscopic Surgery of Female Motion Sickness Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

December 1, 2023

Conditions
Motion SicknessPostoperative Nausea and VomitingIbuprofen
Interventions
DRUG

Ibuprofen

0.8g intravenous injection 30min before the end of the operation

DRUG

sufentanil

0.2ug/kg intravenous injection 30min before the end of the operation

Trial Locations (1)

130000

Second Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Second Hospital of Jilin University

OTHER